Serum brain-derived neurotrophic factor (BDNF) levels in schizophrenia: A systematic review

Shanghai Archives of Psychiatry

Volumn 24, Issue 5, 2012, Pages 250-261

  Cui, Huiru ^a   Jin, Yi ^b   Wang, Jijun ^c   Weng, Xuchu ^b,c   Li, Chunbo ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b INSTITUTE OF PSYCHOLOGY   (China)

^c HANGZHOU NORMAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84876341030     PISSN: 10020829     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1002-0829.2012.05.002     Document Type: Article

References (48)

1. Jiang K D. Psychiatry. 2nd ed. Beijing: People's Health Publishing House, 2010: 116-117.
2. Ashe P C, Berry M D, Boulton A A. Schizophrenia, a neurodegenerative disorder with neurodevelopmental antecedents. Prog Neuropsychopharmacol Biol Psychiatry 2001; 25(4): 691-707.
3. Lewin G R, Barde Y A. Physiology of the neurotrophins. Annu Rev Neurosci 1996: 19: 289-317.
4. Weickert C S, Hyde T M, Lipska B K, Herman M M, Weinberger D R, Kleinman J E. Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia. Mol Psychiatry 2003; 8(6): 592-610.
5. Mellios N, Huang H S, Baker S P, Galdzicka M, Ginns E, Akbarian S. Molecular determinants of dysregulated GABAergic gene expression in the prefrontal cortex of subjects with schizophrenia. Biol Psychiatry 2009; 65(12): 1006-1014.
6. Wong J, Hyde T M, Cassano H L, Deep-Soboslay A, Kleinman J E, Weickert C S. Promoter specific alterations of brain-derived neurotrophic factor mRNA in schizophrenia. Neuroscience 2010; 169(3): 1071-1084.
7. Ashe P C, Chlan-Fourney J, Juorio A V, Li X M. Brain-derived neurotrophic factor (BDNF) mRNA in rats with neonatal ibotenic acid lesions of the ventral hippocampus. Brain Res 2002; 956(1): 126-135.
8. Karege F, Schwald M, Cisse M. Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets. Neurosci Lett 2002; 328(3): 261-264.
9. Toyooka K, Asama K, Watanabe Y, Muratake T, Takahashi M, Someya T, et al. Decreased levels of brain-derived neurotrophic factor in serum of chronic schizophrenic patients. Psychiatry Res 2002; 110(3): 249-257.
10. Pirildar S, Gonul A S, Taneli F, Akdeniz F. Low serum levels of brain-derived neurotrophic factor in patients with schizophrenia do not elevate after antipsychotic treatment. Prog Neuropsychopharmacol Biol Psychiatry 2004; 28(4): 709-713.
11. Tan Y L, Zhou D F, Zou Y Z, Cao L Y, Su J M, Yao F X. The level of brainderived neurotrophic factor in serum in schizophrenia patients with tardive dyskinesia. Chin J Ment Dis 2004; 30(5): 332-334. (in Chinese)
12. Tan Y L, Dong F Z, Lian Y C, Yi Z Z, Xiang Y Z. Decreased BDNF in serum of patients with chronic schizophrenia on long-term treatment with antipsychotics. Neurosci Lett 2005; 382(1-2): 27-32.
13. Grillo R W, Ottoni G L, Leke R, Souza D O, Portela L V, Lara D R. Reduced serum BDNF levels in schizophrenic patients on clozapine or typical antipsychotics. J Psychiatr Res 2007; 41(1-2): 35-35.
14. Li Y G, Tan Y L, Zhou D F, Cao L Y, Yang F D, Zhang X Y, et al. Serum level of brain-derived neurotrophic factor in Long-term treatment of chronic schizophrenic patients. Chin J Ment Dis 2007; 8(33): 482-483. (in Chinese)
15. Ikeda Y, Yahata N, Ito I, Nagano M, Toyota T, Yoshikawa T, et al. Low serum levels of brain-derived neurotrophic factor and epidermal growth factor in patients with chronic schizophrenia. Schizophr Res 2008; 101(1-3): 58-66.
16. Rizos E N, Rontos I, Laskos E, Arsenis G, Michalopoulou P G, Vasilopoulos D, et al. Investigation of serum BDNF levels in drugnaive patients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2008; 32(5): 1308-1311.
17. Chen da C, Wang J, Wang B, Yang S C, Zhang C X, Zheng Y L, et al. Decreased levels of serum brain-derived neurotrophic factor in drug-naive first-episode schizophrenia: relationship to clinical phenotypes. Psychopharmacology (Berl) 2009; 207(3): 375-380.
18. Vinogradov S, Fisher M, Holland C, Shelly W, Wolkowitz O, Mellon S H. Is serum brain-derived neurotrophic factor a biomarker for cognitive enhancement in schizophrenia? Biol Psychiatry 2009; 66(6): 549-553.
19. Xiu M H, Hui L, Dang Y F, Hou T D, Zhang C X, Zheng Y L, et al. Decreased serum BDNF levels in chronic institutionalized schizophrenia on long-term treatment with typical and atypical antipsychotics. Prog Neuropsychopharmacol Biol Psychiatry 2009; 33(8): 1508-1512.
20. Bai Z S, Zhao H Q, Gao Z Q, Zhong A F. Serum level of brain-derived neurotrophic factor in schizophrenic patients with unsuccessful suicide attempt. J Chin Psychiatry 2009; 19(01): 22-24. (in Chinese)
21. Fernandes B S, Massuda R, Torres M, Camargo D, Fries G R, Gama C S, et al. Improvement of schizophrenia with electroconvulsive therapy and serum brain-derived neurotrophic factor levels: Lack of association in a pilot study. Psychiatry Clin Neurosci 2010; 64(6): 663-665.
22. Jindal R D, Pillai A K, Mahadik S P, Eklund K, Montrose D M, Keshavan M S. Decreased BDNF in patients with antipsychotic naive first episode schizophrenia. Schizophr Res 2010; 119(1-3): 47-51.
23. Rizos E N, Michalopoulou P G, Siafakas N, Stefanis N, Douzenis A, Rontos I, et al. Association of serum brain-derived neurotrophic factor and duration of untreated psychosis in first-episode patients with schizophrenia. Neuropsychobiology 2010; 62(2): 87-90.
24. Rizos E N, Papadopoulou A, Laskos E, Michalopoulou P G, Kastania A, Vasilopoulos D, et al. Reduced serum BDNF levels in patients with chronic schizophrenic disorder in relapse, who were treated with typical or atypical antipsychotics. World J Biol Psychiatry 2010; 11(2): 251-255.
25. Carlino D, Leone E, Di Cola F, Baj G, Marin R, Dinelli G, et al. Low serum truncated-BDNF isoform correlates with higher cognitive impairment in schizophrenia. J Psychiatr Res 2011; 45(2): 273-279.
26. Chen D C, Li Y L, Xiu M H, Wang N, Yang K B, Nie Y, et al. Effect of risperidone treatment on serum levels of BDNF and the correlation of between serum BDNF levels and clinical efficiency and cognition improvement in first-episode schizophrenic patient. Chin J Ment Dis 2010; 36(9): 529-532. (in Chinese)
27. Zeng Y, Kuang L, Gan Y, Chen J M, Ai M, Wang W, et al. Expression and significance of serum BDNF in patients with schizophrenia. Journal of Chongqing Medical University 2011; 36(4): 476-478. (in Chinese)
28. Jockers-Scherubl M C, Danker-Hopfe H, Mahlberg R, Selig F, Rentzsch J, Schurer F, et al. Brain-derived neurotrophic factor serum concentrations are increased in drug-naive schizophrenic patients with chronic cannabis abuse and multiple substance abuse. Neurosci Lett 2004; 371(1): 79-83.
29. Shimizu E, Hashimoto K, Watanabe H, Komatsu N, Okamura N, Koike K, et al. Serum brain-derived neurotrophic factor (BDNF) levels in schizophrenia are indistinguishable from controls. Neurosci Lett 2003; 351(2): 111-114.
30. Huang T L, Lee C T. Associations between serum brainderived neurotrophic factor levels and clinical phenotypes in schizophrenia patients. J Psychiatr Res 2006; 40(7): 664-668.
31. Mackin P, Gallagher P, Watson S, Young A H, Ferrier I N. Changes in brain-derived neurotrophic factor following treatment with mifepristone in bipolar disorder and schizophrenia. Aust N Z J Psychiatry 2007; 41(4): 321-326.
32. Zhang X Y, Tan Y L, Zhou D F, Cao L Y, Wu G Y, Xu Q, et al. Serum BDNF levels and weight gain in schizophrenic patients on longterm treatment with antipsychotics. J Psychiatr Res 2007; 41(12): 997-1004.
33. Reis J H. Increased serum levels of brain-derived neurotrophic factor in chronic institutionalized patients with schizophrenia. Neurosci Lett 2008; 439(2): 157-159.
34. Ebrahim S, Clarke M. STROBE: new standards for reporting observational epidemiology, a chance to improve. Int J Epidemiol 2007; 36(5): 946-948.
35. Egger M, Altman D G, Vandenbroucke J P. Commentary: strengthening the reporting of observational epidemiology the STROBE statement. Int J Epidemiol 2007; 36(5): 948-950.
36. Guyatt G H, Oxman A D, Vist G E, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008; 336(7650): 924-926.
37. RevMan 5.1, released on 22 March 2011. Available from http://ims.cochrane.org/revmn. [Accessed 7 October 2012]
38. Egger M, Smith G D, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315(7109): 629-634.
39. Sterne J A C, Bradburn M J, Egger M. Meta-analysis in Stata. In: Egger M, Smith GD, Altman D. Systematic Reviews in Health Care: Meta-Analysis in Context. London: BMJ Books, 2001: 347-369.
40. Rosenberg M S. The file-drawer problem revisited: a general weighted method for calculating fail-safe numbers in metaanalysis. Evolution 2005; 59(2): 464-468.
41. Yang H X, Wu Y L, Ling L, Han L. Effectiveness of extent of lymphadenectomy for survival in patients with resectable nonsmall cell lung cancer. J Evid Based Med 2002; 2(3): 132-139.
42. Su L, Hu H, Chen j, Wang J J, Wang L W, Shi S X. P50 sensory gating studies in schizophrenics: a systematic review. Natl Med J China 2010; 90(29): 2020-2024.(in Chinese)
43. Green M J, Matheson S L, Shepherd A, Weickert C S, Carr V J. Brainderived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis. Mol Psychiatry 2011; 16(9): 960-972.
44. Bus B A, Arias-Vasquez A, Franke B, Prickaerts J, de Graaf J, Voshaar R C. Increase in serum brain-derived neurotrophic factor in met allele carriers BDNF Val66Met polymorphism is specific to males. Neuropsychobiology 2012; 65(4): 183-187.
45. Angelucci F, Brene S, Mathe A A. BDNF in schizophrenia, depression and corresponding animal models. Mol Psychiatry 2005; 10(4): 345-352.
46. Zhang X Y, Liang J, Chen D C, Xiu M H, De Yang F, Kosten T A, et al. Low BDNF is associated with cognitive impairment in chronic patients with schizophrenia. Psychopharmacology (Berl) 2012; 222(2): 277-284.
47. Yi Z H, Zhang C, Wu Z, Hong W, Li Z Z, Fang Y R, et al. Lack of effect of brain derived neurotrophic factor (BDNF) Val66Met polymorphism on early onset schizophrenia in Chinese Han population. Brain Res 2011; 1417(12): 146-150.
48. Zhang X Y, Chen D C, Xiu M H, Haile C N, Luo X, Xu K, et al. Cognitive and serum BDNF correlates of BDNF Val66Met gene polymorphism in patients with schizophrenia and normal controls. Hum Genet 2012; 131(7): 1187-1195.